[Skip to Content]
[Skip to Content Landing]
May 18, 1964


JAMA. 1964;188(7):693-694. doi:10.1001/jama.1964.03060330073027

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:—  The controversy, concerning the treatment of basal cell carcinoma, between surgeons and radiotherapists is not new, but is timely and should be resolved. It is unfortunate that the treatment of such a common lesion should be so controversial and the cause of invective among those responsible for the care of patients. It is no less unfortunate that patients should be exposed to such apparent uncertainty; nor should the patient be placed in the position of having to decide which type of treatment to accept. Most individuals—offered a choice between surgery usually entailing hospitalization and loss of time, and radiotherapy—will prefer the simpler alternative of a few visits to the radiotherapist.Basal cell carcinoma is a common lesion of the face and other exposed parts of the body. It is more common in elderly individuals and is considered to be associated with exposure to the elements—particularly, the sun

First Page Preview View Large
First page PDF preview
First page PDF preview